Global Alosetron Market Insights, Forecast to 2026

Published On: March 2020 | Report ID: 192869 | Category: Pharmaceuticals and HealthcarePages: 118

Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.

The global Alosetron market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2020-2026. The objectives of this study are to define, segment, and project the size of the Alosetron market based on company, product type, end user and key regions.

This report studies the global market size of Alosetron in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alosetron in these regions.

This research report categorizes the global Alosetron market by top players/brands, region, type and end user. This report also studies the global Alosetron market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Sebela Pharmaceuticals


Par Pharmaceutical

West-Ward Pharmaceuticals

Market size by Product

0.5 Tablets

1 mg Tablets

Market size by End User



Market size by Region

North America

United States







South Korea















Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

The study objectives of this report are:

To study and analyze the global Alosetron market size (value & volume) by company, key regions, products and end user, breakdown data from 2015 to 2019, and forecast to 2026.

To understand the structure of Alosetron market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Alosetron companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Alosetron submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alosetron are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alosetron market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Alosetron Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Alosetron Market Size Growth Rate by Product

1.4.2 0.5 Tablets

1.4.3 1 mg Tablets

1.5 Market by End User

1.5.1 Global Alosetron Market Size Growth Rate by End User

1.5.2 Hospital

1.5.3 Drugstore

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Alosetron Market Size

2.1.1 Global Alosetron Revenue 2015-2026

2.1.2 Global Alosetron Sales 2015-2026

2.2 Alosetron Growth Rate by Regions

2.2.1 Global Alosetron Sales by Regions

2.2.2 Global Alosetron Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Alosetron Sales by Manufacturers

3.1.1 Alosetron Sales by Manufacturers

3.1.2 Alosetron Sales Market Share by Manufacturers

3.1.3 Global Alosetron Market Concentration Ratio (CR5 and HHI)

3.2 Alosetron Revenue by Manufacturers

3.2.1 Alosetron Revenue by Manufacturers (2015-2020)

3.2.2 Alosetron Revenue Share by Manufacturers (2015-2020)

3.3 Alosetron Price by Manufacturers

3.4 Alosetron Manufacturing Base Distribution, Product Types

3.4.1 Alosetron Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Alosetron Product Type

3.4.3 Date of International Manufacturers Enter into Alosetron Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Alosetron Sales by Product

4.2 Global Alosetron Revenue by Product

4.3 Alosetron Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Alosetron Breakdown Data by End User

6 North America

6.1 North America Alosetron by Countries

6.1.1 North America Alosetron Sales by Countries

6.1.2 North America Alosetron Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Alosetron by Product

6.3 North America Alosetron by End User

7 Europe

7.1 Europe Alosetron by Countries

7.1.1 Europe Alosetron Sales by Countries

7.1.2 Europe Alosetron Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Alosetron by Product

7.3 Europe Alosetron by End User

8 Asia Pacific

8.1 Asia Pacific Alosetron by Countries

8.1.1 Asia Pacific Alosetron Sales by Countries

8.1.2 Asia Pacific Alosetron Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Alosetron by Product

8.3 Asia Pacific Alosetron by End User

9 Central & South America

9.1 Central & South America Alosetron by Countries

9.1.1 Central & South America Alosetron Sales by Countries

9.1.2 Central & South America Alosetron Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Alosetron by Product

9.3 Central & South America Alosetron by End User

10 Middle East and Africa

10.1 Middle East and Africa Alosetron by Countries

10.1.1 Middle East and Africa Alosetron Sales by Countries

10.1.2 Middle East and Africa Alosetron Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Alosetron by Product

10.3 Middle East and Africa Alosetron by End User

11 Company Profiles

11.1 Sebela Pharmaceuticals

11.1.1 Sebela Pharmaceuticals Company Details

11.1.2 Company Business Overview

11.1.3 Sebela Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Sebela Pharmaceuticals Alosetron Products Offered

11.1.5 Sebela Pharmaceuticals Recent Development

11.2 Amneal

11.2.1 Amneal Company Details

11.2.2 Company Business Overview

11.2.3 Amneal Alosetron Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Amneal Alosetron Products Offered

11.2.5 Amneal Recent Development

11.3 Par Pharmaceutical

11.3.1 Par Pharmaceutical Company Details

11.3.2 Company Business Overview

11.3.3 Par Pharmaceutical Alosetron Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Par Pharmaceutical Alosetron Products Offered

11.3.5 Par Pharmaceutical Recent Development

11.4 West-Ward Pharmaceuticals

11.4.1 West-Ward Pharmaceuticals Company Details

11.4.2 Company Business Overview

11.4.3 West-Ward Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2015-2020)

11.4.4 West-Ward Pharmaceuticals Alosetron Products Offered

11.4.5 West-Ward Pharmaceuticals Recent Development

12 Future Forecast

12.1 Alosetron Market Forecast by Regions

12.1.1 Global Alosetron Sales Forecast by Regions 2020-2026

12.1.2 Global Alosetron Revenue Forecast by Regions 2020-2026

12.2 Alosetron Market Forecast by Product

12.2.1 Global Alosetron Sales Forecast by Product 2020-2026

12.2.2 Global Alosetron Revenue Forecast by Product 2020-2026

12.3 Alosetron Market Forecast by End User

12.4 North America Alosetron Forecast

12.5 Europe Alosetron Forecast

12.6 Asia Pacific Alosetron Forecast

12.7 Central & South America Alosetron Forecast

12.8 Middle East and Africa Alosetron Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Alosetron Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

Please fill the form below, to recieve the report sample

Name of the Company*
Title / Designation*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name of the Company*
Title / Designation*
Your specific requirements*
Human Verification*
Choose License Type

Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.


  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.